Zhen-Zhen Chen, Yu-Yu Niu. 2019: Stem cell therapy for Parkinson’s disease using non-human primate models. Zoological Research, 40(5): 349-357. DOI: 10.24272/j.issn.2095-8137.2019.053
Citation: Zhen-Zhen Chen, Yu-Yu Niu. 2019: Stem cell therapy for Parkinson’s disease using non-human primate models. Zoological Research, 40(5): 349-357. DOI: 10.24272/j.issn.2095-8137.2019.053

Stem cell therapy for Parkinson’s disease using non-human primate models

  • Stem cell therapy (SCT) for Parkinson’s disease (PD) has received considerable attention in recent years. Non-human primate (NHP) models of PD have played an instrumental role in the safety and efficacy of emerging PD therapies and facilitated the translation of initiatives for human patients. NHP models of PD include primates with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism, who are responsive to dopamine replacement therapies, similar to human PD patients. Extensive research in SCT has been conducted to better treat the progressive dopaminergic neurodegeneration that underlies PD. For effective application of SCT in PD, however, a number of basic parameters still need to be tested and optimized in NHP models, including preparation and storage of cells for engraftment, methods of transplantation, choice of target sites, and timelines for recovery. In this review, we discuss the current status of NHP models of PD in stem cell research. We also analyze the advances and remaining challenges for successful clinical translation of SCT for this persistent disease.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return